Pacific Biosciences Of California (PACB) Other Non Operating Income (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Other Non Operating Income of $2.0 million for Q1 2026, down 53.28% year-over-year from $4.3 million in Q1 2025, and up 116.73% quarter-over-quarter from -$12.0 million in Q4 2025.
Pacific Biosciences Of California (PACB) Other Non Operating Income (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Other Non Operating Income history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 53.28% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at -$2.3 million (up 7.18% YoY), while the FY2023 annual figure was $32.7 million, changed N/A from the prior year.
- Other Non Operating Income for Q1 2026 stood at $2.0 million, up from -$12.0 million in the prior quarter.
- The five-year high for Other Non Operating Income was $34.7 million in Q4 2023, with the low at -$19.7 million in Q4 2024.
- The 5-year median for Other Non Operating Income is $4.3 million (2025), against an average of $3.5 million.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income tumbled 129100.0% in 2022, then soared 2791.24% in 2023.
- Pacific Biosciences Of California's Other Non Operating Income stood at -$1.3 million in 2022, then jumped by 2791.24% to $34.7 million in 2023, then sank by 156.8% to -$19.7 million in 2024, then jumped by 39.2% to -$12.0 million in 2025, then surged by 116.73% to $2.0 million in 2026.
- Business Quant data shows PACB's Other Non Operating Income at $2.0 million in Q1 2026, -$12.0 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.01 Mn |
| Dec 31, 2025 | -11.99 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 4.29 Mn |
| Dec 31, 2024 | -19.72 Mn |
| Sep 30, 2024 | 6.89 Mn |
| Jun 30, 2024 | 6.07 Mn |
| Mar 31, 2024 | 6.76 Mn |
| Dec 31, 2023 | 34.72 Mn |
| Jun 30, 2023 | 8.93 Mn |
| Mar 31, 2023 | 6.87 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Mar 31, 2022 | -279,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Jun 30, 2021 | 161,000.00 |
| Mar 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 98.00 Mn |